Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Molecular Endocrinology (Baltimore, Md.)
|
April 1, 1997
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
J Tan, Y Sharief, K G Hamil, et al.
American Journal of Clinical Oncology
|
October 16, 1999
Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer
D Y Zang, K H Lee, J S Lee, et al.
The Korean Journal of Internal Medicine
|
June 1, 1997
A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancer
J S Choi, K H Lee, M J Ahn, et al.
British Journal of Cancer
|
July 31, 2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
J-L Lee, Y-K Kang, H J Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2009
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
D Y Zang, B H Lee, H-C Park, et al.
British Journal of Cancer
|
March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Y-K Kang, H-M Chang, J H Yook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
M-H Ryu, E Baba, K H Lee, et al.
ESMO Open
|
September 21, 2024
Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05
T-Y Kim, S Y Kim, J H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
S J Seong, M Lim, S K Sohn, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Molecular Endocrinology (Baltimore, Md.)
|
April 1, 1997
Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
J Tan, Y Sharief, K G Hamil, et al.
American Journal of Clinical Oncology
|
October 16, 1999
Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer
D Y Zang, K H Lee, J S Lee, et al.
The Korean Journal of Internal Medicine
|
June 1, 1997
A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancer
J S Choi, K H Lee, M J Ahn, et al.
British Journal of Cancer
|
July 31, 2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
J-L Lee, Y-K Kang, H J Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2009
Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
D Y Zang, B H Lee, H-C Park, et al.
British Journal of Cancer
|
March 2, 2013
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)
Y-K Kang, H-M Chang, J H Yook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 2015
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)
M-H Ryu, E Baba, K H Lee, et al.
ESMO Open
|
September 21, 2024
Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05
T-Y Kim, S Y Kim, J H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2020
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial<sup>☆</sup>
S H Park, D H Lim, T S Sohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
S J Seong, M Lim, S K Sohn, et al.
Page
of 2